16
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Vaginal washing and lubrication among female sex workers in the Mexico-US border region: implications for the development of vaginal PrEP for HIV prevention

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          To assess the potential acceptability and inform the development of behaviorally-congruent vaginal douche- or gel-based HIV pre-exposure prophylaxis (PrEP) products, we examined vaginal washing and lubrication practices among female sex workers (FSWs) in Tijuana and Ciudad Juarez, two northern Mexico cities bordering the United States (US).

          Methods

          Two hundred and ninety-five HIV-negative FSWs (145 Tijuana; 150 Ciudad Juarez) enrolled in a behavioral HIV prevention intervention trial completed surveys assessing vaginal washing and lubrication practices, as well as motivators and barriers to performing each practice. Logistic regression was used to identify potential predictors of each practice in the past month.

          Results

          In the past month, vaginal washing was performed by 56 and 22% of FSWs in Tijuana and Ciudad Juarez ( p <  0.0001), respectively, while vaginal lubrication was performed by 64 and 45% of FSWs in Tijuana and Ciudad Juarez ( p = 0.001), respectively. Vaginal washing was positively associated with living in Tijuana (adjusted odds ratio [AOR] = 4.35, 95% confidence interval [CI]: 2.60–7.30), older age (AOR = 1.04 per year, 95% CI: 1.01–1.06), and vaginal lubrication (AOR = 2.99, 95% CI: 1.67–5.35), while it was negatively associated with being born in the same state as the study site (AOR = 0.50, 95% CI: 0.31–0.82), earning a monthly income ≥3500 pesos (AOR = 0.53, 95% CI: 0.28–1.00), and hazardous alcohol consumption (AOR = 0.56, 95% CI: 0.33–0.95). Vaginal lubrication was positively associated with living in Tijuana (AOR = 2.21, 95% CI: 1.37–3.54) and vaginal washing (AOR = 2.91, 95% CI: 1.64–5.18), while it was negatively associated with being born in the same state as the study site (AOR = 0.47, 95% CI: 0.29–0.75).

          Conclusions

          The moderate and high prevalence of vaginal washing and lubrication, respectively, suggest behaviorally-congruent, multi-purpose, vaginal douche- and gel-based PrEP products that simultaneously address FSWs’ needs and prevent HIV infection may be acceptable to many FSWs along the Mexico-US border. Future product development and implementation should also consider the link between vaginal washing and lubrication to ensure existing practices do not undermine vaginal PrEP product effectiveness.

          Trial registration

          ClincialTrials.gov ( NCT02447484).

          Electronic supplementary material

          The online version of this article (10.1186/s12889-018-5946-z) contains supplementary material, which is available to authorized users.

          Related collections

          Most cited references43

          • Record: found
          • Abstract: found
          • Article: not found

          The table 2 fallacy: presenting and interpreting confounder and modifier coefficients.

          It is common to present multiple adjusted effect estimates from a single model in a single table. For example, a table might show odds ratios for one or more exposures and also for several confounders from a single logistic regression. This can lead to mistaken interpretations of these estimates. We use causal diagrams to display the sources of the problems. Presentation of exposure and confounder effect estimates from a single model may lead to several interpretative difficulties, inviting confusion of direct-effect estimates with total-effect estimates for covariates in the model. These effect estimates may also be confounded even though the effect estimate for the main exposure is not confounded. Interpretation of these effect estimates is further complicated by heterogeneity (variation, modification) of the exposure effect measure across covariate levels. We offer suggestions to limit potential misunderstandings when multiple effect estimates are presented, including precise distinction between total and direct effect measures from a single model, and use of multiple models tailored to yield total-effect estimates for covariates.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Vaginal bacteria modify HIV tenofovir microbicide efficacy in African women.

            Antiretroviral-based strategies for HIV prevention have shown inconsistent results in women. We investigated whether vaginal microbiota modulated tenofovir gel microbicide efficacy in the CAPRISA (Centre for the AIDS Program of Research in South Africa) 004 trial. Two major vaginal bacterial community types-one dominated by Lactobacillus (59.2%) and the other where Gardnerella vaginalis predominated with other anaerobic bacteria (40.8%)-were identified in 688 women profiled. Tenofovir reduced HIV incidence by 61% (P = 0.013) in Lactobacillus-dominant women but only 18% (P = 0.644) in women with non-Lactobacillus bacteria, a threefold difference in efficacy. Detectible mucosal tenofovir was lower in non-Lactobacillus women, negatively correlating with G. vaginalis and other anaerobic bacteria, which depleted tenofovir by metabolism more rapidly than target cells convert to pharmacologically active drug. This study provides evidence linking vaginal bacteria to microbicide efficacy through tenofovir depletion via bacterial metabolism.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Safety and Efficacy of a Dapivirine Vaginal Ring for HIV Prevention in Women.

              The incidence of human immunodeficiency virus (HIV) infection remains high among women in sub-Saharan Africa. We evaluated the safety and efficacy of extended use of a vaginal ring containing dapivirine for the prevention of HIV infection in 1959 healthy, sexually active women, 18 to 45 years of age, from seven communities in South Africa and Uganda.
                Bookmark

                Author and article information

                Contributors
                hpines@ucsd.edu
                ssemple@ucsd.edu
                sstrathdee@ucsd.edu
                chendrix@jhmi.edu
                alvera@ucsd.edu
                pgorbach@ucla.edu
                carlos.magis@gmail.com
                gmartinez@femap.org.mx
                tpatterson@ucsd.edu
                Journal
                BMC Public Health
                BMC Public Health
                BMC Public Health
                BioMed Central (London )
                1471-2458
                14 August 2018
                14 August 2018
                2018
                : 18
                : 1009
                Affiliations
                [1 ]Department of Medicine, University of California, San Diego, 9500 Gilman Drive, MC 0507, La Jolla, CA 92093 USA
                [2 ]Department of Psychiatry, University of California, San Diego, 9500 Gilman Drive, MC 0680, La Jolla, CA 92093 USA
                [3 ]ISNI 0000 0001 2171 9311, GRID grid.21107.35, Department of Medicine, , Johns Hopkins University, ; 600 N. Wolfe Street, Baltimore, MD 21287 USA
                [4 ]ISNI 0000 0000 9632 6718, GRID grid.19006.3e, Department of Epidemiology, , University of California, ; Los Angeles, 650 Charles E Young Drive S, BOX 951772, Los Angeles, CA 90095 USA
                [5 ]ISNI 0000 0004 1791 0836, GRID grid.415745.6, Centro Nacional para la Prevención y Control del VIH/SIDA (CENSIDA) Ministry of Health, ; Mexico City, Mexico
                [6 ]Federacion Mexicana de Asociaciones Privadas, Ciudad Juarez, Chihuahua, Mexico
                Author information
                http://orcid.org/0000-0002-7173-1981
                Article
                5946
                10.1186/s12889-018-5946-z
                6092873
                30107833
                a3c2da83-e15f-4909-8819-98f55320200d
                © The Author(s). 2018

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                History
                : 30 October 2017
                : 9 August 2018
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/100000026, National Institute on Drug Abuse;
                Award ID: R01DA039071
                Award ID: K01DA040543
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/100000002, National Institutes of Health;
                Award ID: P30 AI036214
                Categories
                Research Article
                Custom metadata
                © The Author(s) 2018

                Public health
                vaginal practices,pre-exposure prophylaxis,hiv,female sex workers,mexico
                Public health
                vaginal practices, pre-exposure prophylaxis, hiv, female sex workers, mexico

                Comments

                Comment on this article